Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism
- 26 March 2003
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 81 (4) , 246-255
- https://doi.org/10.1007/s00109-002-0414-7
Abstract
Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins. TaqIB polymorphism (B2 allele) identified in intron 1 is associated with lower plasma CETP concentrations and higher HDL cholesterol levels and may play an antiatherogenic role in humans. However, its molecular mechanism remains unclear. To evaluate the association between the promoter polymorphisms and CETP/HDL cholesterol levels, ten novel and three previously reported polymorphisms located within 3.3 kb of the CETP gene promoter were investigated in a sample of 357 elderly Japanese men. All the promoter polymorphisms were in linkage disequilibrium with each other and with TaqIB. The −2505A allele, the "S" allele of the [gaaa]n repeat ("S" denotes [gaaa]n=329 bp and longer, "L" denotes >329 bp) and TaqIB2 allele were significantly associated with both lower plasma CETP concentrations and higher HDL cholesterol levels whereas −971G/A and −629A/C were significantly associated with CETP concentrations but not with HDL-C levels. The 12-polymorphism haplotypes consisting of −2804, −2505, [gaaa]n, −1930, −1674, −1129, −1046, −971, −875, −827, −629, and TaqIB were analyzed. These 12 polymorphisms generated eight main haplotypes, accounting for 86% of the observed haplotypes. The G/A/S/T/T/C/T/A/C/C/A/B2 haplotype was significantly associated with lower CETP concentrations (2.0±0.6 µg/ml) and higher HDL cholesterol levels (55.1±12.7 mg/dl) than the other seven main haplotypes. The 5- and 3-polymorphism haplotype analyses consisting of −2505 and the [gaaa]n repeat indicated the −2505C/A polymorphism might explain the variation in the CETP concentrations best, and the [gaaa]n repeat and/or the −2505C/A polymorphism may independently determine the variation in HDL cholesterol levels, whereas the −629A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations as well as HDL cholesterol levels, although the latter has been frequently examined in many association studies.Keywords
This publication has 33 references indexed in Scilit:
- A novel cholesteryl ester transfer protein promoter polymorphism (−971G/A) associated with plasma high-density lipoprotein cholesterol levelsAtherosclerosis, 2002
- Human Sex Hormone-binding Globulin Promoter Activity Is Influenced by a (TAAAA) Repeat Element within an Alu SequenceJournal of Biological Chemistry, 2001
- Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetesAtherosclerosis, 2001
- Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- New Functional Promoter Polymorphism, CETP/−629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein DeficiencyPreventive Medicine, 1998
- Human Cholesteryl Ester Transfer Protein Gene Proximal Promoter Contains Dietary Cholesterol Positive Responsive Elements and Mediates Expression in Small Intestine and Periphery While Predominant Liver and Spleen Expression Is Controlled by 5′-distal SequencesPublished by Elsevier ,1996
- Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Journal of Clinical Investigation, 1994
- A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.Journal of Clinical Investigation, 1993
- Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.Journal of Clinical Investigation, 1990